Added to YB: 2025-08-12
Pitch date: 2025-08-08
NVO [bullish]
Novo Nordisk A/S
-3.29%
current return
Author Info
Sherwood Investment Letter is building a fund and sharing the stocks they are analyzing and investing in. Sign up for the newsletter.
Company Info
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
Market Cap
DKK 1.4T
Pitch Price
DKK 327.17
Price Target
N/A
Dividend
3.63%
EV/EBITDA
8.96
P/E
13.76
EV/Sales
4.74
Sector
Pharmaceuticals
Category
turnaround
Novo Nordisk looks safer and safer. My stock buy of the week
NVO: Down 20%+ after walking back guidance, but opportunity as price below earnings. Growth slowing but still double-digit. Trading at 12x PE vs 35x before—safer now with upside potential. Buying as others flee, price down to 2022 levels despite 2x earnings. Management made guidance error, but fundamentals intact.
Read full article (4 min)